Title of article :
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B
Author/Authors :
Bjorn Dahlof، نويسنده , , Peter S. Sever، نويسنده , , Neil R. Poulter، نويسنده , , Hans Wedel، نويسنده , , D. Gareth Beevers، نويسنده , , Mark Caulfield، نويسنده , , Rory Collins، نويسنده , , Sverre E Kjeldsen، نويسنده , , Arni Kristinsson، نويسنده , , Gordon T. McInnes، نويسنده , , Jesper Mehlsen، نويسنده , , Markku Nieminen، نويسنده , , Eoin OʹBrien، نويسنده , , Jan ostergren، نويسنده ,
Abstract :
Background
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics and β blockers used. For a given reduction in blood pressure, some suggested that newe
